Grove Bank & Trust Pfizer Inc Transaction History

Grove Bank & Trust

$739 Million
Q1 2025

A detailed history of Grove Bank & Trust transactions in Pfizer Inc stock. As of the latest transaction made, Grove Bank & Trust holds 26,531 shares of PFE stock, worth $597,743. This represents 0.09% of its overall portfolio holdings.

Number of Shares

26,531

Previous 24,977 6.22%

Holding current value

$597,743

Previous $662,000 1.51%

% of portfolio

0.09%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$25.01 - $27.13 $38,865 - $42,160	1,554 Added 6.22%	26,531 $672,000
Q4 2024 Jan 16, 2025	BUY	$24.8 - $30.19 $5,704 - $6,943	230 Added 0.93%	24,977 $662,000
Q3 2024 Oct 11, 2024	SELL	$27.7 - $31.39 $83,875 - $95,048	-3,028 Reduced 10.9%	24,747 $716,000
Q2 2024 Jul 24, 2024	SELL	$25.26 - $29.6 $96,341 - $112,894	-3,814 Reduced 12.07%	27,775 $777,000
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $491,884 - $564,840	-18,999 Reduced 37.56%	31,589 $876,000
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $120,642 - $156,700	-4,617 Reduced 8.36%	50,588 $1.46 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $114,882 - $134,285	3,580 Added 6.93%	55,205 $1.83 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $65,232 - $75,472	1,806 Added 3.63%	51,625 $1.89 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $119,430 - $155,480	3,032 Added 6.48%	49,819 $2.03 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $194,221 - $253,534	-4,652 Reduced 9.04%	46,787 $2.4 Million
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $55,575 - $67,843	-1,270 Reduced 2.41%	51,439 $2.25 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $123,630 - $146,586	-2,657 Reduced 4.8%	52,709 $2.76 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $64,050 - $79,366	-1,400 Reduced 2.47%	55,366 $2.87 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $3,388 - $5,022	82 Added 0.14%	56,766 $3.35 Million
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $123,323 - $158,419	3,142 Added 5.87%	56,684 $2.44 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $76,344 - $86,485	2,126 Added 4.13%	53,542 $2.1 Million
Q1 2021 Apr 23, 2021	SELL	$33.49 - $37.77 $36,738 - $41,433	-1,097 Reduced 2.09%	51,416 $1.86 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $138,565 - $176,198	4,140 Added 8.56%	52,513 $1.93 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $86,899 - $101,953	-2,737 Reduced 5.36%	48,373 $1.78 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $185,900 - $225,524	6,172 Added 13.73%	51,110 $1.67 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $115,282 - $164,714	4,265 Added 10.49%	44,938 $1.47 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $47,964 - $54,433	1,457 Added 3.72%	40,673 $1.59 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $176,973 - $229,482	5,447 Added 16.13%	39,216 $1.41 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $3,143 - $3,529	85 Added 0.25%	33,769 $1.46 Million
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $77,737 - $85,407	2,073 Added 6.56%	33,684 $1.43 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $115,410 - $131,580	3,000 Added 10.49%	31,611 $1.38 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $2,861 - $3,470	-83 Reduced 0.29%	28,611 $1.26 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $30,011 - $31,995	-910 Reduced 3.07%	28,694 $1.04 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $7,020 - $8,144	220 Added 0.75%	29,604 $1.05 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $4,224 - $4,481	127 Added 0.43%	29,384 $1.06 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $906,967 - $999,126	29,257	29,257 $1.04 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.57B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $126B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account